U.S. Pharmacist Weekly News Update
May 29, 2019

International Panel Advises Against Most Subclinical Hypothyroidism Treatment
Pharmacists are increasingly filling more prescriptions for patients with subclinical hypothyroidism, but an international panel suggests that shouldn’t be the case. Find out why the group recommends against hormone treatment for most of those patients, even while prescriptions doubled over a 10-year period.


Nearly Half of People in United States Use Prescription Drugs Over a Month
Many Americans are filling prescription drugs each month, based on statistics from a national health survey. The CDC reports that nearly half of the U.S. population used one or more prescription drugs over a 1-month period, even though the percentage has been declining. Here are more details.

Treatment of Both Bowel, Brain Function Might Help Alleviate
IBS Symptoms

Irritable bowel syndrome (IBS) is the most common digestive disorder in the United States, affecting more than 25 million people, and a new study suggests that just treating the bowels isn’t optimal. Find out why the Swedish study considers it so important to consider brain signaling to the gut when trying to alleviate IBS symptoms.

Despite ‘Safer’ Reputation, Tramadol Postsurgery Often Leads to Extended Use
Pharmacists might consider tramadol a less risky opioid than some other options. A new study challenges that view among government agencies and healthcare professionals, however. Find out how much more often postsurgical patients used tramadol for an extended period of time compared with other opioid formulations.


Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App